Drug Delivery Technologies Market - Forecast(2024 - 2030)
1. Drug Delivery Technologies Market - Overview
1.1 Definitions and Scope
2. Drug Delivery Technologies Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Drug Delivery Technologies Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Drug Delivery Technologies Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Drug Delivery Technologies Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Drug Delivery Technologies Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Drug Delivery Technologies Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Drug Delivery Technologies Market - By Route of Administration (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Product Segment Analysis
8.3.1 Introduction
8.3.2 Oral Drug Delivery
8.3.2.1 Solid Oral Drugs
8.3.2.1.1 Tablets
8.3.2.1.2 Capsules
8.3.2.1.3 Powders
8.3.2.1.4 Pills
8.3.2.2 Liquid Oral Drugs
8.3.2.2.1 Solutions
8.3.2.2.2 Syrups
8.3.2.3 Semi-Solid Oral Drugs
8.3.2.3.1 Gels
8.3.2.3.2 Emulsions
8.3.2.3.3 Elixirs
8.3.3 Pulmonary Drug Delivery
8.3.3.1 Formulations
8.3.3.2 Devices
8.3.3.2.1 Metered Dose Inhalers
8.3.3.2.2 Dry Powder Inhalers
8.3.3.2.3 Nebulizers
8.3.3.2.3.1 Jet Nebulizers
8.3.3.2.3.2 Ultrasonic Nebulizers
8.3.3.2.3.3 Soft Mist Nebulizers
8.3.4 Injectable Drug Delivery
8.3.4.1 Devices
8.3.4.1.1 Conventional Injection Devices
8.3.4.1.1.1 By Material
8.3.4.1.1.2 Glass
8.3.4.1.1.3 Plastic
8.3.4.1.1.4 By Product
8.3.4.1.1.4.1 Fillable Syringes
8.3.4.1.1.4.2 Prefilled Syringes
8.3.4.1.1.5 By Usability
8.3.4.1.1.5.1 Reusable Syringes
8.3.4.1.1.5.2 Disposable Syringes
8.3.4.1.2 Self-Injection Devices
8.3.4.1.2.1 Needle-Free Injectors
8.3.4.1.2.2 Autoinjectors
8.3.4.1.2.3 Pen Injectors
8.3.4.1.2.4 Wearable Injectors
8.3.4.1.3 Other Injector Devices
8.3.4.2 Formulations
8.3.4.2.1 Conventional Drug Delivery
8.3.4.2.2 Novel Drug Delivery Formulations
8.3.4.2.3 Long-Acting Injection Formulations
8.3.5 Ocular Drug Delivery
8.3.5.1 Formulations
8.3.5.1.1 Liquid Formulations
8.3.5.1.1.1 Eye Drops
8.3.5.1.1.2 Liquid Sprays
8.3.5.1.2 Semi-Solid Formulations
8.3.5.1.2.1 Gels
8.3.5.1.2.2 Eye Ointments
8.3.5.2 Ocular Devices
8.3.5.2.1 Drug-Coated Contact Lenses
8.3.5.2.2 Ocular Inserts
8.3.6 Nasal Drug Delivery
8.3.6.1 Nasal Drops
8.3.6.2 Nasal Sprays
8.3.6.3 Nasal Powders
8.3.6.4 Nasal Gels
8.3.7 Topical Drug Delivery
8.3.7.1 Formulations
8.3.7.1.1 Liquid Topical Drug Delivery
8.3.7.1.1.1 Solutions
8.3.7.1.1.2 Suspensions
8.3.7.1.2 Semi-Solid Topical Drug Delivery
8.3.7.1.2.1 Creams
8.3.7.1.2.2 Gels
8.3.7.1.2.3 Ointments
8.3.7.1.2.4 Pastes
8.3.7.1.2.5 Lotions
8.3.7.1.3 Solid Topical Drug Delivery
8.3.7.1.3.1 Suppositories
8.3.7.1.3.2 Powders
8.3.7.2 Devices (Transdermal Drug Delivery)
8.3.7.2.1 Transdermal Patches
8.3.7.2.2 Transdermal Gels
8.3.8 Implantable Drug Delivery
8.3.8.1 Active Implantable Drug Delivery
8.3.8.2 Passive Implantable Drug Delivery
8.3.9 Transmucosal Drug Delivery
8.3.9.1 Oral Transmucosal Drug Delivery
8.3.9.1.1 Buccal Drug Delivery
8.3.9.1.2 Sublingual Drug Delivery
8.3.9.2 Other Transmucosal Drug Delivery
8.3.9.2.1 Rectal Transmucosal Drug Delivery
8.3.9.2.2 Vaginal Transmucosal Drug Delivery
9. Drug Delivery Technologies Market - By Type (Market Size -$Million / $Billion)
10. Drug Delivery Technologies - By End-User (Market Size -$Million / $Billion)
10.1 Hospitals
10.2 Ambulatory Surgical Centers/Clinics
10.3 Home Care Settings
10.4 Diagnostic Centers
10.5 Other Facilities of Use
11. Drug Delivery Technologies- By Geography (Market Size -$Million / $Billion)
11.1 Drug Delivery Technologies Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Drug Delivery Technologies- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Drug Delivery Technologies- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Drug Delivery Technologies - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong Kong
11.8.5.9 Rest of APAC
11.9 Drug Delivery Technologies - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Drug Delivery Technologies Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Drug Delivery Technologies Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at a global level - Top 10 companies
13.1.6 Best Practises for companies
14. Drug Delivery Technologies Market - Key Company List by Country Premium
15. Drug Delivery Technologies Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 3M Company
15.3 Bayer AG
15.4 F. Hoffmann-La Roche Ltd.
15.5 Glaxosmithkline PLC
15.6 Novartis AG
15.7 Sanofi
15.8 Company 7
15.9 Company 8 & More
*Financials would be provided on a best efforts basis for private companies
16. Drug Delivery Technologies Market - Appendix
16.1 Abbreviations
16.2 Sources
17. Drug Delivery Technologies Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
LIST OF FIGURES
1.US North American Drug Delivery Technologies Market Revenue, 2023-2030 ($M)2.Canada North American Drug Delivery Technologies Market Revenue, 2023-2030 ($M)
3.Mexico North American Drug Delivery Technologies Market Revenue, 2023-2030 ($M)
4.Brazil North American Drug Delivery Technologies Market Revenue, 2023-2030 ($M)
5.Argentina North American Drug Delivery Technologies Market Revenue, 2023-2030 ($M)
6.Peru North American Drug Delivery Technologies Market Revenue, 2023-2030 ($M)
7.Colombia North American Drug Delivery Technologies Market Revenue, 2023-2030 ($M)
8.Chile North American Drug Delivery Technologies Market Revenue, 2023-2030 ($M)
9.Rest of South America North American Drug Delivery Technologies Market Revenue, 2023-2030 ($M)
10.UK North American Drug Delivery Technologies Market Revenue, 2023-2030 ($M)
11.Germany North American Drug Delivery Technologies Market Revenue, 2023-2030 ($M)
12.France North American Drug Delivery Technologies Market Revenue, 2023-2030 ($M)
13.Italy North American Drug Delivery Technologies Market Revenue, 2023-2030 ($M)
14.Spain North American Drug Delivery Technologies Market Revenue, 2023-2030 ($M)
15.Rest of Europe North American Drug Delivery Technologies Market Revenue, 2023-2030 ($M)
16.China North American Drug Delivery Technologies Market Revenue, 2023-2030 ($M)
17.India North American Drug Delivery Technologies Market Revenue, 2023-2030 ($M)
18.Japan North American Drug Delivery Technologies Market Revenue, 2023-2030 ($M)
19.South Korea North American Drug Delivery Technologies Market Revenue, 2023-2030 ($M)
20.South Africa North American Drug Delivery Technologies Market Revenue, 2023-2030 ($M)
21.North America North American Drug Delivery Technologies By Application
22.South America North American Drug Delivery Technologies By Application
23.Europe North American Drug Delivery Technologies By Application
24.APAC North American Drug Delivery Technologies By Application
25.MENA North American Drug Delivery Technologies By Application
26.Novartis AG, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.F. Hoffmann-La Roche Ltd., Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Bayer AG, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Glaxosmithkline PLC, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.3M Company, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Sanofi, Sales /Revenue, 2015-2018 ($Mn/$Bn)